The Seizure of Nexperia: A Cautionary Tale for European Investments
Less than two years ago, European authorities assessed the risks associated with China controlling Nexperia through Wingtech and subsequently gave the green light for the acquisition. However, in a surprising turn of events, the Netherlands has utilized a 1952 emergency law to confiscate the very same company, arguing that it is strategic for European security.
Why is this important? The lurching approach of European regulators — oscillating between being too stringent and excessively lenient — is detrimental. Europe has exhibited a glaring inconsistency in defining what is considered strategic . This lack of a coherent criterion poses significant risks for companies looking to invest in technology sectors in Europe. With the knowledge that regulations can shift retroactively, the endurance of external pressures paints a rather shaky landscape for potential investments.
This inconsistency does not come without a significant cost; potential investors are left uncertain about the sustainability of their investments. The shift in regulatory environments can scare away outside investment, leading to an ultimately less competitive marketplace for European businesses.
The contradiction:
- If Nexperia was deemed so strategic for Europe, why was it allowed to be sold to a consortium backed by the Chinese government in 2017?
- If it wasn’t a concern back then, what has changed now to warrant a seizure under a law designed for supply crises ?
The only plausible explanation is that miscalculations were made, and they were made on a grand scale.
Between the lines: The editorial of Financial Times bluntly states that the Netherlands made a mistake in approving the sale and is now attempting to correct it. However, this inconsistent approach sets a toxic precedent. Companies can pass through all regulatory filters, invest billions, and operate successfully for years under European oversight, only to find themselves suddenly facing state action that deems the initial decision wrong.
After Wingtech acquired Nexperia in 2019, European regulators had ample opportunity to block the deal. They did not take action. For years, Nexperia operated within the Netherlands, manufacturing millions of components for the European automotive and consumer electronics industries, all without a hiccup in legal or regulatory compliance.
Turning point: The issue at hand is not Nexperia’s technological capabilities or its strategic importance, but rather the geopolitical pressure influencing this abrupt decision:
- The United States blacklisted Wingtech in 2024.
- In September 2025, the U.S. extended restrictions to all subsidiaries of sanctioned companies.
- Court documents suggest that the Netherlands acted under American pressure, rather than conducting its own risk assessments.
Yes, but: Wingtech has made a valid point: this decision reflects “excessive interference driven by geopolitical bias rather than fact-based risk assessment.” This is a contrasting approach to the one taken when the sale was initially approved, highlighting a significant shift in regulatory focus.
The money trail: Nexperia has invested in its European facilities under the guidance of Zhang Xuezheng. The company maintained operations in the Netherlands, created jobs, and contributed to local economies through taxes. Instead of gratitude, it received confiscation under a 1952 law and the suspension of its CEO, without any formal accusations of mismanagement.
The stakes are alarmingly high. Consider these ramifications:
- 12,500 employees face an uncertain future.
- A CEO is suspended in Amsterdam.
- China has enacted an export veto on certain components from its Guangdong plant.
- European automobile industries remain dependent on Nexperia’s chips.
All of this turmoil arises from a situation where a sale was approved less than two years ago, following a comprehensive risk evaluation. Now that risks are deemed unacceptable, Europe stands at a crossroads. If it wishes to attract technological investment , the continent must establish clear and consistent criteria for what is considered strategic. It cannot afford to give approval to operations for years, only to confiscate companies when geopolitical climates shift. This, rather than safeguarding technological sovereignty , is ultimately an act of improvised governance disguised as national security.
In conclusion, the unfolding situation around Nexperia serves as a clarion call for Europe to reevaluate its approach to foreign investments in critical sectors. The balance between national security and economic growth is delicate, but inconsistencies in policy may erode Europe’s competitive edge in the global market.